A new study suggests Medicare's mandatory bundled payments led to a modest reduction in spending, an upcoming Advisory Board webconference examines important updates to CMS' pay-for-performance programs, and more.
John Mendelsohn served as president of M.D. Anderson from 1996 to 2011, in today's bite-sized hospital and health industry news from California, Pennsylvania, and Texas.
When an 8-year-old girl came to the Arizona Burn Center for treatment, Kevin Foster, the center's director, instantly thought of his daughter—but Foster quickly had to redirect his attention and remain focused on the patient, who needed extensive, painful skin grafts.
The U.S. cancer death rate has been dropping for 25 years—but even so, 600,000 Americans likely will die of the disease this year, according to a new American Cancer Society report. Explore the leading causes of cancer deaths, and find out cancer's toll in your state, on our interactive maps.
CMS' change in diagnosis coding may be responsible for over 50% of the reduction in 30-day hospital readmissions, according to a study published Monday in Health Affairs. Advisory Board's Eric Fontana and Kenna Hawes respond that the study adds to growing evidence that the program should have been tested further before being rolled out.
In 2017, Timberlands Healthcare, a rural hospital in Crockett, Texas, became one of the many rural hospitals in Texas to shut its doors, but with the help of two Austin-based physicians, the hospital reopened under a new name and a new vision for the future, Charlotte Huff reports for Kaiser Health News.
The Supreme Court on Monday heard oral arguments in a case centered on whether a drugmaker is liable under state law for drug-related injuries when FDA denies the drugmaker's request to revise a product's warning label.
FDA Commissioner Scott Gottlieb says the agency has suspended all routine inspections of U.S. food-processing facilities because of the partial government shutdown, which caused FDA to furlough about 41% of its staff, but he is working on a plan to bring back some food inspectors as soon as next week to inspect facilities that are considered high-risk.
23andMe on Tuesday announced that it will offer personalized weight-loss advice to consumers based on their genetic data, but some scientists are skeptical that the product will actually produce results.
Print All Daily Briefing Article from
01/10/2019
Share:
Have a Question?
x
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.
